Additional Tests

• Bone scan – If the urologist suspects disease extension in the bone (usually ifthe PSA is greater than 15 or 20 ng / ml).

• CT

•MRI

Through thousands of patients’ data statistical processing, i.e. who underwent radical prostatectomy, there is an over 80% certainty predection regarding postoperative stage and total disease treatment incidence rate.

Preoperatively, we may also examine:

• value of PSA levels before biopsy;

• disease clinical stage;

• Gleason score cancer.

Tumor cells may vary in shape and size. Some malignancies may be aggressive, but others may not.

Partin tables have been developed by urologists Partin and Walsh to predict final biopathology cancer state. Based on PSA levels, biopsy’s Gleason score along with clinical findings may calculate the probability of each of the following four pathological findings: prostate limited disease, cancer expansion beyond prostate, seminal vesicles’ and lymph nodes’ filtration.